Vera Therapeutics Inc (VERA)
42.31
+2.73
(+6.90%)
USD |
NASDAQ |
May 01, 16:00
42.31
0.00 (0.00%)
After-Hours: 20:00
Vera Therapeutics Net Income (Quarterly): -25.66M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -25.66M |
| September 30, 2023 | -20.10M |
| June 30, 2023 | -20.16M |
| March 31, 2023 | -30.07M |
| December 31, 2022 | -32.44M |
| September 30, 2022 | -24.68M |
| June 30, 2022 | -14.85M |
| March 31, 2022 | -17.08M |
| Date | Value |
|---|---|
| December 31, 2021 | -16.85M |
| September 30, 2021 | -7.611M |
| June 30, 2021 | -3.437M |
| March 31, 2021 | -4.714M |
| December 31, 2020 | -42.88M |
| September 30, 2020 | -4.46M |
| June 30, 2020 | -3.604M |
| March 31, 2020 | -2.474M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-42.88M
Minimum
Dec 2020
-2.474M
Maximum
Mar 2020
-16.94M
Average
-16.97M
Median
Net Income (Quarterly) Benchmarks
| Vertex Pharmaceuticals Inc | 968.80M |
| Alpine Immune Sciences Inc | 5.96M |
| Fate Therapeutics Inc | -44.12M |
| Checkpoint Therapeutics Inc | -19.13M |
| Mersana Therapeutics Inc | -19.54M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 27.03M |
| EPS Diluted (Quarterly) | -0.58 |
| Enterprise Value | 2.044B |
| Earnings Yield | -5.41% |